Literature DB >> 32674202

Pilot Randomized Controlled Trial of Diabetes Group Prenatal Care.

Ebony B Carter1, Kate Barbier1, Pamela K Hill2, Alison G Cahill3, Graham A Colditz4, George A Macones3, Methodius G Tuuli5, Sara E Mazzoni6.   

Abstract

OBJECTIVE: This study aimed to determine the feasibility and effectiveness of Diabetes Group Prenatal Care to increase patient engagement in diabetes self-care activities. STUDY
DESIGN: A pilot randomized controlled trial was conducted at two sites. Inclusion criteria were English or Spanish speaking, type 2 or gestational diabetes, 22 to 34 weeks of gestational age at first study visit, ability to attend group care at specified times, and willingness to be randomized. Exclusion criteria included type 1 diabetes, multiple gestation, major fetal anomaly, serious medical comorbidity, and serious psychiatric illness. Women were randomized to Diabetes Group Prenatal Care or individual prenatal care. The primary outcome was completion of diabetes self-care activities, including diet, exercise, blood sugar testing, and medication adherence. Secondary outcomes included antenatal care characteristics, and maternal, neonatal, and diabetes management outcomes. Analysis followed the intention-to-treat principle.
RESULTS: Of 159 eligible women, 84 (53%) consented to participate in the study and were randomized to group (n = 42) or individual (n = 42) prenatal care. Demographic characteristics were similar between study arms. Completion of diabetes self-care activities was similar overall, but women in group care ate the recommended amount of fruits and vegetables on more days per week (5.1 days/week ± 2.0 standard deviation [SD] in group care vs. 3.4 days ± 2.6 SD in individual care; p < 0.01) and gained less weight per week during the study period (0.2 lbs/week [interquartile range: 0-0.7] vs. 0.5 lbs/week [interquartile range: 0.2-0.9]; p = 0.03) than women in individual care. Women with gestational diabetes randomized to group care were 3.5 times more likely to have postpartum glucose tolerance testing than those in individual care (70 vs. 21%; relative risk: 3.5; 95% confidence interval: 1.4-8.8). Other maternal, neonatal, and pregnancy outcomes were similar between study arms.
CONCLUSION: Diabetes group care is feasible and shows promise for decreasing gestational weight gain, improving diet, and increasing postpartum diabetes testing among women with pregnancies complicated by diabetes. KEY POINTS: · Women with gestational diabetes in group care were 3.5 times more likely to return for postpartum glucose tolerance testing.. · Women with gestational diabetes in group care had less gestational weight gain during the study period.. · Diabetes Group Prenatal Care is a promising intervention to improve outcomes for women with diabetes in pregnancy.. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32674202      PMCID: PMC7855154          DOI: 10.1055/s-0040-1714209

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   3.079


  22 in total

Review 1.  The increasing prevalence of diabetes in pregnancy.

Authors:  Kelly J Hunt; Kelly L Schuller
Journal:  Obstet Gynecol Clin North Am       Date:  2007-06       Impact factor: 2.844

2.  ACOG Practice Bulletin No. 101: Ultrasonography in pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-02       Impact factor: 7.661

3.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

4.  Improved adequacy of prenatal care and healthcare utilization among low-income Latinas receiving group prenatal care.

Authors:  S Darius Tandon; Fallon Cluxton-Keller; Lucinda Colon; Patricia Vega; Alina Alonso
Journal:  J Womens Health (Larchmt)       Date:  2013-10-12       Impact factor: 2.681

5.  Group prenatal care for women with gestational diabetes (.).

Authors:  Sara E Mazzoni; Pamela K Hill; Kelsey W Webster; Gretchen A Heinrichs; M Camille Hoffman
Journal:  J Matern Fetal Neonatal Med       Date:  2015-11-23

Review 6.  Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis.

Authors:  Caroline K Kramer; Sara Campbell; Ravi Retnakaran
Journal:  Diabetologia       Date:  2019-03-07       Impact factor: 10.122

7.  A United States national reference for fetal growth.

Authors:  G R Alexander; J H Himes; R B Kaufman; J Mor; M Kogan
Journal:  Obstet Gynecol       Date:  1996-02       Impact factor: 7.661

8.  Criteria for screening tests for gestational diabetes.

Authors:  M W Carpenter; D R Coustan
Journal:  Am J Obstet Gynecol       Date:  1982-12-01       Impact factor: 8.661

9.  The effectiveness of implementing a reminder system into routine clinical practice: does it increase postpartum screening in women with gestational diabetes?

Authors:  A K Shea; B R Shah; H D Clark; J Malcolm; M Walker; A Karovitch; E J Keely
Journal:  Chronic Dis Can       Date:  2011-03

10.  Markers of maternal and infant metabolism are associated with ventricular dysfunction in infants of obese women with type 2 diabetes.

Authors:  W Todd Cade; Philip T Levy; Rachel A Tinius; Mehgna D Patel; Swati Choudhry; Mark R Holland; Gautam K Singh; Alison G Cahill
Journal:  Pediatr Res       Date:  2017-06-28       Impact factor: 3.756

View more
  1 in total

Review 1.  Adherence to Antidiabetic Medications among Women with Gestational Diabetes.

Authors:  Michelle Asiedu-Danso; Irene A Kretchy; Jeremiah Kobby Sekyi; Augustina Koduah
Journal:  J Diabetes Res       Date:  2021-08-06       Impact factor: 4.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.